Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3402688 | Enfermedades Infecciosas y Microbiología Clínica | 2008 | 5 Pages |
Abstract
To achieve VL < 400 copies/mL at delivery, antiretroviral prophylaxis should be started before 26 to 28 weeks of pregnancy. A potent and well-tolerated prophylactic antiretroviral regimen will likely reduce the time to virological response. Trials investigating alternative regimens (e.g., lopinavir-containing) for patients with late diagnosis during prenatal care or VL >100,000 copies/mL are warranted.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Ricardo Palacios, Jorge F. Senise, Maria José R. Vaz, Adauto Castelo,